March 6, 2026

Disclaimer: The information provided here is for educational purposes only and is not intended as medical advice. It should not be used to diagnose, treat, cure, or prevent any medical condition. Instead, use it as a starting point for discussion with your healthcare provider. Always consult with a qualified healthcare provider before starting any new medication, supplement, device, or making changes to your health regimen.
In the wake of the COVID-19 pandemic, a complex and multifaceted health crisis has emerged, leaving millions of individuals grappling with debilitating, lingering symptoms. For those living with Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and related dysautonomia, the daily reality is often defined by profound exhaustion, cognitive impairment, and unpredictable symptom flares. While much of the early focus on these conditions centered around immune dysfunction and viral persistence, a new and critical area of medical research has come to the forefront: severe metabolic and mitochondrial impairment. Patients are increasingly discovering that their cellular engines are stalling, and their bodies are struggling to process energy efficiently.
One of the most alarming discoveries in recent post-viral research is the high prevalence of new-onset insulin resistance and metabolic dysfunction in patients who were previously healthy. When the cells cannot properly respond to insulin or generate adenosine triphosphate (ATP) within the mitochondria, the entire systemic network suffers. This is where targeted nutritional interventions like Sensitol™ come into play. By combining specific, naturally occurring isomers of inositol with the potent antioxidant alpha-lipoic acid, this formulation aims to address the root biochemical pathways of energy production. In this comprehensive guide, we will explore the intricate mechanisms of these compounds, how chronic illness disrupts our metabolic equilibrium, and how supporting cellular health may offer a pathway toward improved quality of life.
Long COVID and ME/CFS are strongly linked to mitochondrial dysfunction and new-onset insulin resistance.
Sensitol™ combines inositol isomers and alpha-lipoic acid to support cellular energy and metabolic health.
Targeted metabolic support may help manage post-viral fatigue, brain fog, and blood sugar dysregulation.
Always consult your healthcare provider before starting supplements, especially if taking blood sugar medications.
To understand how Sensitol™ works, we must first dive into the molecular biology of its primary ingredients: myo-inositol (MI) and D-chiro-inositol (DCI). Inositols are naturally occurring sugar alcohols found in a variety of plant and animal foods, and they are synthesized endogenously within the human body. While they are often informally grouped with B-vitamins, they are actually distinct structural isomers that play an absolutely critical role as secondary messengers in cellular signaling. When a hormone—most notably insulin—binds to a receptor on the surface of a cell, it cannot physically enter the cell to exert its effects. Instead, it relies on a complex intracellular relay system to transmit its instructions to the nucleus and the metabolic machinery.
Myo-inositol and D-chiro-inositol serve as the direct precursors to these secondary messengers, known as inositol phosphoglycans (IPGs). However, MI and DCI regulate entirely different branches of glucose metabolism. Myo-inositol is primarily responsible for facilitating cellular glucose uptake. When insulin docks at its receptor, MI-derived messengers activate the phosphatidylinositol-3-kinase (PI3K) and protein kinase B (AKT) pathways. This biochemical cascade triggers the translocation of GLUT4 transport proteins from the interior of the cell to the outer membrane, effectively opening the doors for glucose to leave the bloodstream and enter the cell. Tissues with extraordinarily high energy demands, such as the brain, heart, and ovaries, rely heavily on this MI-driven pathway to maintain their function.
Conversely, D-chiro-inositol is responsible for what happens to that glucose once it is inside the cell. DCI is synthesized directly from MI via an insulin-dependent enzyme called epimerase. Once created, DCI-derived messengers primarily control non-oxidative glucose disposal. They downregulate an enzyme known as glycogen synthase kinase 3β (GSK3β) while simultaneously stimulating pyruvate dehydrogenase. This complex enzymatic shift channels cellular glucose away from immediate circulation and directs it toward ATP energy production and glycogen storage, predominantly within the liver and skeletal muscles. In a healthy human body, the physiological ratio of MI to DCI in blood plasma is tightly regulated at approximately 40:1, ensuring a perfect balance between glucose uptake and energy storage.
The third key component of Sensitol™ is alpha-lipoic acid (ALA), a naturally occurring compound that has garnered immense attention in the fields of metabolic health and biohacking. ALA is unique among antioxidants because it is amphipathic, meaning it is both water-soluble and fat-soluble. This dual solubility allows it to easily penetrate cellular membranes, cross the highly selective blood-brain barrier, and integrate into the lipid-rich myelin sheaths that protect our nerves. Because it can travel virtually anywhere in the body, ALA is often referred to as the "universal antioxidant," capable of neutralizing free radicals in both the aqueous cytoplasm and the fatty cellular walls.
Beyond its role as a free radical scavenger, ALA is an obligatory co-factor for critical mitochondrial enzymes. Mitochondria are the microscopic powerhouses within our cells responsible for generating ATP through a process called the Krebs cycle (or TCA cycle). Alpha-lipoic acid is essential for the function of two major enzyme complexes within this cycle: pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase. Without adequate levels of ALA, these enzymatic reactions stall, the Krebs cycle halts, and the cell's ability to convert glucose and amino acids into usable energy is severely impaired. In this way, ALA acts as the biochemical spark plug that keeps the mitochondrial engine running smoothly.
Furthermore, inside the body, ALA is rapidly reduced to its active form, dihydrolipoic acid (DHLA). The ALA/DHLA redox couple possesses a remarkable ability to regenerate and recycle other depleted endogenous antioxidants. When molecules like Vitamin C, Vitamin E, and glutathione neutralize a free radical, they become oxidized and inactive. DHLA can donate electrons to these oxidized molecules, restoring them to their active, protective states. This continuous recycling profoundly amplifies the body's innate antioxidant defense system, making ALA an indispensable molecule for maintaining cellular resilience in the face of physiological stress.
The combination of MI, DCI, and ALA in Sensitol™ is not coincidental; it represents a highly targeted, synergistic approach to metabolic health. While the inositol isomers work at the cell membrane to ensure that insulin signals are heard and glucose is successfully transported indoors, alpha-lipoic acid works deep within the mitochondria to ensure that the imported glucose is efficiently burned for energy rather than stored as ectopic fat. This multi-tiered support system addresses the entire lifecycle of cellular energy production.
By supporting both the insulin signaling cascade and the mitochondrial Krebs cycle simultaneously, these ingredients help prevent the metabolic bottlenecks that lead to cellular starvation and systemic fatigue. When glucose uptake is optimized and mitochondrial respiration is unhindered, cells can maintain the high ATP output required for optimal neurological, cardiovascular, and muscular function. This synergy is particularly vital for individuals whose metabolic pathways have been disrupted by chronic illness, viral infections, or prolonged systemic inflammation.